Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cirrhosis: early-phase trial registry
29 of 54 indexed Cirrhosis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #261 of 28,707 conditions by registered trial count.
54 US clinical trials · 29 currently recruiting · #261 of 28,707 conditions by registered trial count
Cirrhosis: 54 US clinical trials tracked, 29 recruiting.
Cirrhosis is the subject of 54 registered US clinical trials on ClinicalTrials.gov, 29 of them currently open to new participants. 7 are in Phase 3-4 (later-stage) and 20 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), running 5 of these trials.
Enrollment posture brief
Registry condition cirrhosis
OPEN 29 | RECR 54% | LATE 7 | EARLY 20 | RANK #261 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Uterine Cancer (54% recruiting · 28 trials)
Cirrhosis lists 29 open slots (54% of 54 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cirrhosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cirrhosis is recruiting above its size-band peers.
29 of 54 indexed trials (53.7%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cirrhosis trials is spread across many organizations.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) accounts for 5 of 54 trials (9.3%). 37 distinct sponsors appear on at least one study for this condition label.
-
Most Cirrhosis trials plan to enrol fewer than 100 people.
Median target enrolment is 47 among the 54 trials that report a genuine target (sentinel values excluded). 35 of those (64.8%) plan for fewer than 100 participants.
-
Cirrhosis research is mostly interventional.
41 interventional and 13 observational studies make up this index (75.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
54 total, page 2 of 2
Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
NCT00802555
Gabapentin to Treat Itch in Patients With Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00058890
Ramelteon for Treatment of Insomnia in Cirrhosis
Virginia Commonwealth University
NCT03091738
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound
Northwell Health
NCT01208311
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 13 |
| Phase 3 | 4 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Cirrhosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cirrhosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cirrhosis page
54 registered trials, 29 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 29 Cirrhosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) sponsors the most Cirrhosis trials on record, review their full trial history before evaluating a specific study. See National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cirrhosis condition card totals 54 registered trials; most-linked intervention Placebo; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.